ReBio Pharma is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve.
SiSu® is designed to steadily release effective levels of therapeutics within the eye while safely dissolving once drug release is completed, and can be tuned to the drug, indication, and duration of release required.
ReBio Pharma is leveraging Sisu® to create a new franchise to transform the standard of care for the millions of patients around the world living with chronic eye disease.
Discover more at www.rebiopharma.com
Company Details
- Employees
- 24
- Founded
- -
- Address
- Smart Chemistry Park, Raisionkaari 55,finland
- Industry
- Biotechnology
- Website
- rebio.co.uk
- Keywords
- PreclinApps.
- HQ
- Raisio
Rebio Questions
Rebio's website is rebio.co.uk
Rebio's LinkedIn profile is https://fi.linkedin.com/company/rebiopharma
Rebio has
24 employees.
View email and phone details for 24
employees at Rebio.
Rebio's industry is
Biotechnology
Rebio's top competitors are
Trigone Pharma,
Sanaclis,
Bayer,
Preclinapps,
Pibond,
Scienta,
Delsitech Ltd,
Montisera Ltd,
Aleva Neurotherapeutics Sa,
Gyrus Capital.
Rebio's categories are Biotechnology
Rebio's founding year is 2015
